cicaprost

This page covers all cicaprost drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Prostacyclin receptor, Prostaglandin D2 receptor, Prostaglandin E2 receptor EP1 subtype.

Targets

Prostacyclin receptor, Prostaglandin D2 receptor, Prostaglandin E2 receptor EP1 subtype

Phase 2 pipeline (1)

• CICAPROST · Hematology
  Cicaprost works by binding to and activating the prostacyclin receptor, mimicking the effects of prostacyclin to promote vasodilation and inhibit platelet aggregation.

Patent intelligence

• cicaprost patent landscape — aggregated cliff calendar, attackable patents, originator estates